21 Stocks Moving in Monday's Pre-Market Session

Gainers

• Valneva SE VALN rose 34.4% to $37.69 in pre-market trading after the company disclosed positive Phase 3 results for inactivated, adjuvanted COVID-19 vaccine candidate VLA2001.
• Xiaobai Maimai Inc. HX rose 24.6% to $7.35 in pre-market trading after jumping 31% on Friday.
• Agile Therapeutics, Inc. AGRX rose 17.8% to $0.8950 in pre-market trading. The company said Executive Edelman Joseph bought 8.42 million shares at average price of $0.58.
• Sonnet BioTherapeutics Holdings, Inc. SONN rose 9.9% to $0.7202 in pre-market trading.
• InMed Pharmaceuticals Inc. INM shares rose 9.3% to $1.53 in pre-market trading. InMed Pharmaceuticals recently announced completion of BayMedica acquisition.
• Dynavax Technologies Corporation DVAX rose 9.2% to $18.50 in pre-market trading. Valneva disclosed positive Phase 3 results for inactivated, adjuvanted COVID-19 vaccine candidate VLA2001. Dynavax is a supplier of CpG 1018 adjuvant.
• Camber Energy, Inc. CEI rose 8.8% to $1.49 in pre-market trading after declining around 4% on Friday.
• Greenpro Capital Corp. GRNQ rose 7.2% to $0.9580 in pre-market trading after jumping around 19% on Friday.
• Bitfarms Ltd. BITF shares rose 6.9% to $5.75 in pre-market trading after gaining 7% on Friday.
• FuelCell Energy, Inc. FCEL shares rose 6.6% to $7.88 in pre-market trading.
• Arbutus Biopharma Corporation ABUS rose 6.1% to $4.33 in pre-market trading.
• Baidu, Inc. BIDU rose 5.4% to $172.44 in pre-market trading. China is said to consider asking Tencent to allow Baidu, others to search WeChat, Bloomberg reported.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Communications Systems, Inc. JCS shares fell 44.3% to $4.70 in pre-market trading. Today is ex-dividend date for a $3.50 per share special dividend.
• Revance Therapeutics, Inc. RVNC shares fell 31.9% to $15.47 in pre-market trading. The FDA issued a Complete Response Letter (CRL) regarding Revance Therapeutics’ marketing application for DaxibotulinumtoxinA for Injection for moderate to severe glabellar (frown) lines.
• Avadel Pharmaceuticals plc AVDL fell 20.4% to $7.95 in pre-market trading. Avadel Pharmaceuticals reported ongoing FDA review of NDA for FT218 for patients with narcolepsy.
• Ocugen, Inc. OCGN shares fell 10.4% to $7.76 in pre-market trading. Technical Advisory Group of WHO will meet on October 26th to consider emergency use listing for Ocugen partner Bharat Biotech's Covaxin, according to Times Now.
• UP Fintech Holding Limited TIGR fell 9.4% to $7.17 in pre-market trading after dipping 24% on Friday.
• Futu Holdings Limited FUTU fell 8% to $58.64 in pre-market trading. Futu Holdings shares dipped over 24% on Friday on reports of Chinese regulators working to improve rules and supervision in the broker and consumer finance sectors.
• LM Funding America, Inc. LMFA fell 7.4% to $4.40 in pre-market trading after surging 18% on Friday.
• Zillow Group, Inc. Z shares fell 6.7% to $88.60 in pre-market trading. After buying more than 3,800 homes in the second quarter, Zillow Group has announced that it will make no further purchases for the rest of the year, according to a report from Bloomberg.
• Cemtrex, Inc. CETX fell 6.3% to $1.05 in pre-market trading after gaining over 8% on Friday.